Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001221150 | SCV001393176 | pathogenic | Familial cancer of breast; Fanconi anemia complementation group J | 2021-05-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with BRIP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 949645). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser861Phefs*2) in the BRIP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BRIP1 are known to be pathogenic (PMID: 16116423, 17033622, 21964575). |
Myriad Genetics, |
RCV003336345 | SCV004044544 | pathogenic | Familial cancer of breast | 2023-06-07 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |
Baylor Genetics | RCV003336345 | SCV004214682 | likely pathogenic | Familial cancer of breast | 2023-10-11 | criteria provided, single submitter | clinical testing |